Skip to main content
    H

    HCW Biologics Inc (HCWB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.76
    -0.04 (-5.31%)

    Market Cap: $1.73M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    HCW Biologics Inc (HCWB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    HCW Biologics (HCWB) has a market cap of $1.73M and an enterprise value of $7.61M. Revenue grew 1502.05% over the last 12 months from the 12 months before. Its net debt of $5.88M equals 339.89% of its market cap.

    Total Valuation

    Enterprise value is 339.89% above the market cap, as debt exceeds cash.

    Market Cap$1.73M
    Enterprise Value$7.61M
    Latest price (Nov 17, 2026)$0.76

    Key Dates

    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 58.28% in the quarter ended Sep 30, 2026.

    Shares Outstanding2.10M
    Shares Change (QoQ)+58.28%

    Valuation Ratios

    Sales and book value multiples are 0.2x and 0.2x.

    P/S Ratio0.2x
    Forward P/S0.3x
    P/B Ratio0.2x

    Price Statistics

    The stock is down 95.79% over 52 weeks and trades 47.59% below its 50-day average.

    Beta (1Y)1.12
    52-Week Change-95.79%
    1-Month Change-38.41%
    3-Month Change-67.07%
    6-Month Change-88.09%
    5-Year Change-99.90%
    Total Return (1Y)-95.79%
    Total Return (3Y CAGR)-85.76%
    Total Return (5Y CAGR)-74.40%
    Max Drawdown (1Y)-95.87%
    Max Drawdown (3Y)-99.82%
    Sharpe Ratio (1Y)-1.41
    Correlation with SPY (1Y)0.07
    50-Day Average$1.45
    200-Day Average$3.72
    52-Week Range$0.74 to $23.94
    RSI (14 Days)23.5
    Average Volume (20 Days)43.52K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.07x current liabilities, and total debt is 1.00x shareholder equity.

    Current Ratio0.07x
    Quick Ratio0.07x
    Debt / Equity1.00x
    Interest Coverage1.67x

    Returns and Efficiency

    Return on invested capital is -51.63% and return on equity is -62.29% over the last 12 months.

    Return on Equity (ROE)-62.29%
    Return on Assets (ROA)-16.92%
    Return on Invested Capital (ROIC)-51.63%
    ROA (5Y Average)-55.06%
    Asset Turnover0.27x
    Receivables Turnover732.86x

    Scores

    HCWB has an Altman Z-Score of -7.95, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-7.95
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $6.76M over the last 12 months.

    Revenue$6.76M
    Revenue Growth (YoY)+1502.05%
    Gross Profit$6.47M
    Operating Income-$6.96M
    Pretax Income-$3.84M
    Net Income-$4.25M
    Reported EPS (TTM)-$16.83

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.14% of the $25.13M in total assets.

    Cash and Equivalents$955.46K
    Total Debt$6.83M
    Net Debt$5.88M
    Net Debt Per Share$2.80
    Working Capital-$16.33M
    Shareholder Equity$6.82M
    Book Value Per Share$3.25
    Total Assets$25.13M
    Total Liabilities$18.30M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$11.52M
    FCF Per Share-$5.15
    Depreciation and Amortization$546.16K
    Share Repurchases$406.07K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -102.96%.

    Gross Margin95.72%
    Operating Margin-102.96%
    Pretax Margin-56.77%
    Net Margin-62.87%

    Growth

    Revenue fell 79.94% a year over 3 years.

    Revenue Growth (3Y CAGR)-79.94%
    Revenue Growth (5Y CAGR)-57.90%

    Revenue and profit by year

    Dividends and Yields

    HCWB does not pay a dividend.

    Buyback Yield-801.32%
    Shareholder Yield-801.32%

    Stock Splits

    The last split was a 1-for-6 reverse split on Jun 30, 2026.

    Last Split DateJun 30, 2026
    Split TypeReverse split
    Split Ratio1:6

    Peer Position

    Against 5 similar companies, HCWB has the 3rd highest ROIC.

    ROIC-51.63% vs -61.86% median
    Revenue Growth (Trailing 4 Quarters, YoY)+1502.05% vs -100.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 12215.61% a year over the next fiscal year.

    Revenue Growth Forecast (1Y CAGR)+12215.61%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About HCWB

    What is HCWB's market cap?

    HCW Biologics has a market cap of $1.73M. Its enterprise value, which adds debt and subtracts cash, is $7.61M.

    How many shares of HCWB are outstanding?

    HCW Biologics has 2.10M shares outstanding.

    Does HCWB pay a dividend?

    No. HCW Biologics does not pay a dividend.

    How much debt does HCWB have?

    HCW Biologics has $6.83M of total debt and $955.46K of cash and equivalents, a net debt position of $5.88M.